Stock PME PRO MEDICUS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pro Medicus Limited

Equities

PME

AU000000PME8

Advanced Medical Equipment & Technology

Market Closed - Australian S.E.
Other stock markets
 02:10:05 2024-04-29 am EDT 		5-day change 1st Jan Change
111.6 AUD +2.08% Intraday chart for Pro Medicus Limited +7.25% +16.51%
Apr. 02 Pro Medicus Limited authorizes a Buyback Plan. CI
Apr. 01 Pro Medicus Limited announces an Equity Buyback for 10,442,488 shares, representing 10% of its issued share capital. CI

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,620 2,750 6,119 4,406 6,855 11,422 - -
Enterprise Value (EV) 1 2,588 2,709 6,060 4,318 6,735 11,294 11,247 11,185
P/E ratio 138 x 120 x 199 x 99.4 x 113 x 144 x 110 x 86.8 x
Yield 0.42% 0.45% 0.26% 0.52% 0.46% 0.35% 0.45% 0.6%
Capitalization / Revenue 52.3 x 48.4 x 90.1 x 47.1 x 54.9 x 71.2 x 56.1 x 45.6 x
EV / Revenue 51.7 x 47.7 x 89.3 x 46.2 x 53.9 x 70.4 x 55.2 x 44.7 x
EV / EBITDA 81 x 72.2 x 121 x 61.9 x 73.5 x 96.1 x 74 x 58.4 x
EV / FCF 99.3 x 101 x 187 x 100 x 109 x 151 x 117 x 93.7 x
FCF Yield 1.01% 0.99% 0.54% 1% 0.92% 0.66% 0.85% 1.07%
Price to Book 53.2 x 45.7 x 74.9 x 43.3 x 49.4 x 62.4 x 47.1 x 36 x
Nbr of stocks (in thousands) 103,617 103,947 104,212 104,282 104,432 104,425 - -
Reference price 2 25.29 26.46 58.72 42.25 65.64 109.4 109.4 109.4
Announcement Date 8/21/19 8/19/20 8/17/21 8/17/22 8/14/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 50.1 56.82 67.88 93.46 124.9 160.5 203.7 250.5
EBITDA 1 31.96 37.53 49.89 69.75 91.62 117.5 151.9 191.5
EBIT 1 25.88 29.85 42.69 62.43 83.7 108.1 141.6 180.3
Operating Margin 51.65% 52.53% 62.89% 66.8% 67.01% 67.38% 69.54% 71.98%
Earnings before Tax (EBT) 1 26.12 30.02 42.87 63.08 86.13 110.8 145.5 186
Net income 1 19.12 23.08 30.85 44.44 60.65 79.22 103.4 131.2
Net margin 38.17% 40.61% 45.45% 47.55% 48.56% 49.36% 50.78% 52.39%
EPS 2 0.1830 0.2210 0.2950 0.4250 0.5800 0.7581 0.9946 1.260
Free Cash Flow 1 26.06 26.82 32.43 43.13 61.89 74.86 96 119.4
FCF margin 52.01% 47.19% 47.77% 46.15% 49.55% 46.65% 47.14% 47.68%
FCF Conversion (EBITDA) 81.53% 71.45% 65% 61.84% 67.55% 63.69% 63.19% 62.37%
FCF Conversion (Net income) 136.27% 116.21% 105.12% 97.05% 102.04% 94.51% 92.82% 91%
Dividend per Share 2 0.1050 0.1200 0.1500 0.2200 0.3000 0.3841 0.4895 0.6598
Announcement Date 8/21/19 8/19/20 8/17/21 8/17/22 8/14/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2 2026 S1
Net sales 1 29.29 27.53 31.59 36.3 44.33 49.13 56.89 68.01 74.11 83.66 96.45 109.7 121
EBITDA 1 18.48 19.05 21.98 27.91 33.27 36.48 41.48 50.14 51.18 61.73 - - -
EBIT 1 14.7 15.15 18.3 24.39 29.7 32.73 37.59 46.1 46.78 58.31 64.96 73.55 83.45
Operating Margin 50.19% 55.02% 57.94% 67.2% 67.01% 66.61% 66.09% 67.78% 63.12% 69.7% 67.35% 67.04% 68.95%
Earnings before Tax (EBT) - - - - - - - 48.03 - - - - -
Net income 1 12.05 11.02 13.54 17.31 20.68 23.77 27.19 33.46 36.25 41.3 - - -
Net margin 41.15% 40.04% 42.87% 47.69% 46.64% 48.37% 47.79% 49.2% 48.91% 49.36% - - -
EPS 2 0.1154 0.1056 0.1295 0.1655 0.1971 0.2279 0.2596 0.3204 0.3461 0.4145 0.4700 0.5100 0.5800
Dividend per Share 2 0.0600 - - 0.0800 0.1000 - - 0.1700 - 0.2000 - - -
Announcement Date 2/12/20 8/19/20 2/16/21 8/17/21 2/15/22 8/17/22 2/14/23 8/14/23 2/14/24 - - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 32.3 41.2 59.2 88.3 120 128 175 237
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 26.1 26.8 32.4 43.1 61.9 74.9 96 119
ROE (net income / shareholders' equity) 45.3% 42.2% 43.5% 48.5% 50.4% 49.3% 48.8% 47.7%
ROA (Net income/ Total Assets) 26.3% 25.7% 27.9% 31.4% 33.8% 35.2% 36.9% 37.1%
Assets 1 72.66 89.96 110.6 141.3 179.6 225.2 280.4 353.4
Book Value Per Share 2 0.4800 0.5800 0.7800 0.9800 1.330 1.750 2.320 3.040
Cash Flow per Share 2 0.2400 0.3000 0.3700 0.5900 0.6000 0.8000 0.9900 1.270
Capex 1 0.34 7.57 7.69 9.02 6.45 7.74 9.14 10.5
Capex / Sales 0.68% 13.32% 11.33% 9.65% 5.16% 4.82% 4.49% 4.17%
Announcement Date 8/21/19 8/19/20 8/17/21 8/17/22 8/14/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pro Medicus Limited

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
109.4 AUD
Average target price
95.57 AUD
Spread / Average Target
-12.62%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+16.51% 7.45B
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.36% 32.47B
SECTRA AB Stock Sectra AB
+22.82% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.29% 3.17B
OMNICELL, INC. Stock Omnicell, Inc.
-25.96% 1.28B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-0.13% 893M
VERADIGM INC. Stock Veradigm Inc.
-24.12% 857M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-18.36% 693M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. PME Stock
  4. Financials Pro Medicus Limited